You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
2025 › February › 06
Zepbound
17 months ago
Zepbound and Mounjaro have now underperformed expectations for two straight quarters.
Eli Lilly beats on earnings even as weight loss, diabetes drug sales fall short ○
Zepbound and Mounjaro have now underperformed expectations for two straight quarters.
Eli Lilly beats on earnings even as weight loss, diabetes drug sales fall short ○
Zepbound and Mounjaro have now underperformed expectations for two straight quarters.
page 1 of 1